Influence of amifostine on late radiation-toxicity in head and neck cancer - A follow-up study

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 1953-1956

  Büntzel, Jens ^a,c   Glatzel, Michael ^b,c   Mücke, Ralph ^c   Micke, Oliver ^c   Bruns, Frank ^c,d  

^a Südharzkrankenhaus Nordhausen ^*  (Germany)

^b Suhl Central Hospital   (Germany)

^c German Working Group on Trace Elements and Electrolytes in Oncology (AKTE)   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amifostine; Follow up; Head and neck cancer; Late toxicity; Radiotherapy

Indexed keywords

AMIFOSTINE;

ADULT; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CELL PROTECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION INJURY; TASTE DISORDER; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; AMIFOSTINE; ANTINEOPLASTIC AGENTS; DEGLUTITION DISORDERS; ESOPHAGEAL STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHEDEMA; MALE; MIDDLE AGED; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; TASTE DISORDERS; TIME FACTORS; XEROSTOMIA;

EID: 34250782558     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Seegenschmiedt MH: Nebenwirkungen in der Onkologie, Springer Berlin, 1998.
2. Brizel D, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W and Sauer R: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18: 3339-3345, 2000.
3. Antonadou D, Pepelassi, Synodinou M, Puglisi M and Throuvalas N: Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer. Int J Radiat Oncol Biol Phys 52: 739-747, 2000.
4. Büntzel J, Küttner K, Fröhlich D and Glatzel M: Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 9: 505-509, 1998.
5. Büntzel J, Micke O, Adamietz IA, Monnier A, Glatzel M and De Vries A: Intravenous amifostine during chemoradiotherapy for head-and-neck cancer. A randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64: 684-691, 2006.
6. Micke O, Bruns F, Mücke R, Schäfer U, Glatzel M, de Vries A, Schönekaes K, Kisters K and J Büntzel: Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys 56: 40-49, 2003.
7. Büntzel J, Weinaug R, Glatzel M, Fröhlich D, Micke O, Schüller P and Küttner K: Sodium selenite in the treatment of interstitial post-irradiation edema of the head and neck area. Trace Elem Electrolytes 19: 33-37, 2002.